IJPR  articles are Indexed in SCOPUSClick Here     Impact Factor for Five Years is 0.13 (2013 - 2018).    

logo

INTERNATIONAL JOURNAL OF PHARMACEUTICAL RESEARCH

A Step Towards Excellence

IJPR included in UGC-Approved List of Journals - Ref. No. is SL. No. 4812 & J. No. 63703

ISSN
0975-2366
5 - Years Impact Factor

Year 2012 - 2016

Impact Factor: 1.55

Total Publications: 317

Total Citation: 491

Year 2011 - 2015

Impact Factor: 1.46

Total Publications: 326

Total Citation: 477

Year 2010 - 2014

Impact Factor: 1.3

Total Publications: 313

Total Citation: 407

Year 2009 - 2013

Impact Factor: 0.973

Total Publications: 293

Total Citation: 285

Current Issue
22nd NATIONAL CONVENTION

22nd National Convention of Society of Pharmacognosy & International Conference. For more details visit


For More Detail Visit ncsp.ganpatuniversity.ac.in
Article In Press
No Data found.
ADOBE READER

(Require Adobe Acrobat Reader to open, If you don't have Adobe Acrobat Reader)

Index Page 1
Click here to Download
IJPRT ISSUE

January - March 6 [1] 2014

Click to download
IJPR 9[3] July - September 2017 Special Issue

July - September 9[3] 2017

Click to download
 

Article Detail

Label
Label
Comparison Between effect of Silymarin Extract and Legalon70 in Cyclosporine A-Induced Toxicity in Rats

Author: SAMERA ALKATIB
Abstract: Silymarin is the active constituent of milk thistle seeds consist of four flavonolignan isomers with antioxidant and protection features on hepatocytes against damage. Currently, the commercial silymarin preparations are available and used in the alternative medicine for liver diseases. The aim of this study was to compared the effect of silymarin extracted from milk thistle seeds with commercial one (Legalon 70) in blood and tissues against cyclosporine A– induced toxicity in rats. Twenty-four albino male rats of 3 months age were divided into four groups: Group (1) control, maintain on control diet. Group2 (CsA) treated with 20mg/Kg subcutaneous injection of cyclosporine A. Group3 (CsA + siL) treated with 20mg/Kg CsA and 5mg single oral dose of silymarin daily. Group 4 (CsA + Leg) treated with 20 mg/Kg CsA and 5mg single oral dose of Legalon 70daily. After 3 weeks of the treatment, rats were sacrificed and the serum, Liver, and kidney tissues were collected for analysis. CsA-toxicity was evaluated by decreased serum total protein, albumin, and HDL levels and increased serum alanine aminotransferase (ALT), aspartate aminotransferase (AST), bilirubin, creatinine, total cholesterol, triglycerides, and LDL levels. In liver and kidney, toxicity was assessed by reducing total protein and GsH and increasing MDA concentrations. Both silymarin extract and Legalon 70 showed a close effects in improving liver and kidney functions, and significantly recovery the blood and tissues parameters to approximately normal levels. None of the blood or tissues parameters differed significantly in (CsA + SIL) or (CsA + Leg) group. This study indicated that is a possibility to use the silymarin extract for liver patients as an alternative medicine and dispense with the commercial preparations.
Keyword: (CsA + siL),Group2,bilirubin, creatinine.
DOI: https://doi.org/10.31838/ijpr/2019.11.03.039
Download: Request For Article
 












ONLINE SUBMISSION
USER LOGIN


Username
Password
Login | Register
Pharmacovigilance: Current Scenario and Emerging Trends

National Conference sponsored by GUJCOST on 03.08.2019 at SNLPCP, Umrakh

Download Brochure
News & Events
0.12
2018CiteScore
 
8th percentile
Powered by  Scopus
Google Scholar

hit counters free
0.07
2017CiteScore
 
11th percentile
Powered by  Scopus
Impact Factor for five years is 1.55 (2012 - 2016)

Year 2011 - 2015 Impact Factor - 1.46 Total Publications - 326 Total Citations - 477